Endari

Active Ingredient(s): L-Glutamine
FDA Approved: * July 7, 2017
Pharm Company: * EMMAUS MEDCL
Category: Vitamins & Supplements

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Endari Overview

Glutamine (abbreviated as Gln or Q; encoded by the codons CAA and CAG) is an α-amino acid that is used in the biosynthesis of proteins. It contains an α-amino group (which is in the protonated −NH3+ form under biological conditions), an α-carboxylic acid group (which is in the deprotonated −COO− form under biological conditions), and a side chain amide which replaces the side chain hydroxyl of glutamic acid with an amine functional group, classifying it as a c...

Read more Endari Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Glutamine

Recent Endari Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

L-Glutamine
  • For Solution: 5gm/packet
  • Powder: 5g
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Endari: (1 result)

Sorted by National Drug Code
  • 42457-420 Endari 5 g/1 Oral Powder, for Solution by Emmaus Medical, Inc.

Other drugs which contain L-Glutamine or a similar ingredient: (2 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 20 October 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.